Hemab Therapeutics Holdings, Inc. 8-K

What Happened
Hemab Therapeutics Holdings, Inc. (COAG) issued a press release on May 21, 2026 announcing the company's financial results for the quarter ended March 31, 2026. The press release is furnished as Exhibit 99.1 to the Current Report on Form 8‑K filed the same day.

Key Details

• 8-K filing date: May 21, 2026.
• Reporting period: quarter ended March 31, 2026.
• The press release containing the quarterly results is furnished as Exhibit 99.1.
• The company states the information is being furnished (not “filed”) and therefore is not subject to Section 18 liability and is not incorporated by reference into other filings unless expressly stated.

Why It Matters
This 8‑K notifies investors that Hemab has released its latest quarterly financial results; investors should review the Exhibit 99.1 press release (available on EDGAR or the company website) for revenue, earnings, cash position, and management commentary. The filing’s “furnished, not filed” status is a legal notice about liability and incorporation into other SEC filings, but does not change the need to read the underlying results to assess the company’s near‑term performance.